|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 25 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2009-05-21 |
4 |
B |
$17.82 |
$53 |
I/I |
3 |
194,105 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-10 |
4 |
B |
$19.48 |
$195 |
I/I |
10 |
194,115 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-11 |
4 |
B |
$19.36 |
$407 |
I/I |
21 |
194,136 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-12 |
4 |
B |
$19.70 |
$276 |
I/I |
14 |
194,150 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-20 |
4 |
B |
$17.88 |
$1,439 |
I/I |
80 |
194,151 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-05-21 |
4 |
B |
$17.82 |
$178 |
I/I |
10 |
194,161 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$919 |
I/I |
34 |
194,218 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$934 |
I/I |
34 |
194,252 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,209 |
I/I |
44 |
194,296 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-07 |
4 |
B |
$26.14 |
$1,125 |
I/I |
43 |
194,339 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-08 |
4 |
B |
$26.10 |
$706 |
I/I |
27 |
194,366 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-09 |
4 |
B |
$26.25 |
$1,286 |
I/I |
49 |
194,415 |
2.17 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
57,873 |
194,762 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2004-03-15 |
4 |
B |
$16.11 |
$136,497 |
I/I |
8,471 |
194,952 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2003-10-06 |
4 |
B |
$10.80 |
$1,858,140 |
I/I |
172,050 |
195,162 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$139,904 |
I/I |
5,340 |
197,404 |
2.25 |
- |
|
DDXS |
Diadexus Inc |
10% Owner |
|
2010-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
198,140 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-09 |
4 |
B |
$26.24 |
$38,897 |
I/I |
1,478 |
198,882 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-21 |
4 |
S |
$5.55 |
$11,452 |
I/I |
(2,063) |
201,087 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2013-09-25 |
4 |
B |
$56.63 |
$59,461,500 |
I/I |
1,050,000 |
202,583 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$112,343 |
I/I |
4,225 |
203,107 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-19 |
4 |
S |
$5.64 |
$143,750 |
I/I |
(25,265) |
203,150 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-07 |
4 |
B |
$6.37 |
$15,212 |
I/I |
2,223 |
203,310 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-28 |
4 |
B |
$12.70 |
$210,837 |
I/I |
16,579 |
204,151 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
4 |
B |
$1.87 |
$229,685 |
I/I |
94,306 |
204,336 |
1.5 |
- |
|
1397 Records found
|
|
Page 25 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|